Tvardi Therapeutics (TVRD) Interest & Investment Income (2024 - 2026)

Tvardi Therapeutics has reported Interest & Investment Income for 3 years, with the latest figure at $247000.0 in Q1 2026.

• Quarterly Interest & Investment Income fell 10.18% year-over-year to $247000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$803000.0 (down 203.48% YoY) and the FY2025 annual result came in at $8000.0, down 98.93% from the prior year.
• Interest & Investment Income advanced to $247000.0 in Q1 2026 per TVRD's latest filing, from -$1.1 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $275000.0 in Q1 2025 and troughed at -$1.1 million in Q4 2025.
• A 3-year average of -$3375.0 and a median of $147500.0 in 2024 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income sank 899.24% in 2025, then declined 10.18% in 2026.
• Over 3 years, Interest & Investment Income stood at $132000.0 in 2024, then tumbled by 899.24% to -$1.1 million in 2025, then surged by 123.41% to $247000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $247000.0, -$1.1 million, and $20000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.